Hospital
Sa Hospital Acquisition Group
Sa Hospital Acquisition Group was paid $8.82M by Medicaid between Jan 2018 and Aug 2023, across 59 billing codes. Its largest line is X4003, — 32% of everything it billed.
33Billing provider infoSA HOSPITAL ACQUISITION GROUP
ST. LOUIS, MO 63118
ST. LOUIS, MO 63118
33aNPI1912109919assigned 06/01/2007
33bProvider typePsychiatric Hospital Unit
28Total paid$8.82M
24GClaims104,929
24DCodes billed59
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Psychiatric Hospital Unit providers in Missouri
Rank by total paid#5 of 9
Median peer was paid$8.82M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,176 | $2.47M | |
| 2019 | 21,725 | $1.91M | |
| 2020 | 10,248 | $844K | |
| 2021 | 28,653 | $1.50M | |
| 2022 | 12,113 | $1.12M | |
| 2023 | 9,014 | $967K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4003 | 32% | 6,860 | 4,050 | $2.86M | |
| X4011 | State-specific procedure code | 16% | 7,288 | 6,660 | $1.45M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 3,220 | 2,902 | $987K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.0% | 2,097 | 1,995 | $445K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.0% | 2,983 | 2,869 | $444K |
| 90870 | 4.8% | 3,502 | 1,429 | $420K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.8% | 9,669 | 8,642 | $332K |
| Y7506 | 3.5% | 7,788 | 4,060 | $307K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.3% | 6,366 | 1,683 | $292K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.3% | 2,649 | 2,435 | $206K |
| 81001 | 2.1% | 3,138 | 3,010 | $188K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 5,146 | 4,698 | $169K |
47 more codes
| 80053 | Comprehensive metabolic panel | 1.8% | 4,855 | $162K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 6,375 | $97K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 6,345 | $96K |
| 81025 | <1% | 1,417 | $76K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,016 | $66K |
| G0378 | Hospital observation service, per hour | <1% | 233 | $65K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 922 | $43K |
| 83735 | <1% | 1,078 | $21K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 63 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 309 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 147 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 417 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 231 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 209 | $7K |
| 87276 | <1% | 113 | $5K | |
| 87275 | <1% | 115 | $4K | |
| 20610 | <1% | 27 | $4K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 12 | $2K |
| 85610 | <1% | 74 | $2K | |
| 82962 | <1% | 1,689 | $2K | |
| 85730 | <1% | 72 | $2K | |
| 93970 | <1% | 25 | $2K | |
| 84484 | <1% | 170 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $1K |
| 93925 | <1% | 15 | $871.64 | |
| J3490 | Unclassified drugs | <1% | 12,036 | $859.53 |
| 83605 | <1% | 114 | $807.45 | |
| 82550 | <1% | 151 | $632.83 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 99 | $493.21 |
| 73562 | <1% | 16 | $441.58 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $420.80 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $420.80 |
| 73565 | <1% | 14 | $319.30 | |
| 80061 | Lipid panel | <1% | 78 | $297.16 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 19 | $213.12 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15 | $167.68 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 48 | $154.02 |
| 83690 | <1% | 26 | $88.64 | |
| 82607 | <1% | 12 | $81.42 | |
| 87070 | <1% | 12 | $59.57 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 55 | $12.08 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 2,399 | $0.00 |
| A6197 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 0% | 17 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 29 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 29 | $0.00 |
| 11721 | 0% | 41 | $0.00 | |
| C1780 | Lens, intraocular (new technology) | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEFILIPPI, BIANCA (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Sa Hospital Acquisition Group, LLC | Saint Louis, MO | $256K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.